1 Regression of left ventricular hypertrophy provides an additive physiological benefit following treatment of aortic stenosis: Insights from serial coronary wave intensity analysis.

2 A compartmental approach to isosteviol's disposition in Sprague-Dawley rats.

3 Synthesis and anti-cancer activities of glycosides and glycoconjugates of diterpenoid isosteviol.

4 Resistance exercise training promotes fiber type-specific myonuclear adaptations in older adults.

5 evaluation of the relation between adenoids hypertrophy and cranial base angles

6 protective role for lpa3 in cardiac hypertrophy induced by myocardial infarction but not by isoproterenol

7 prognostic value of qtc interval dispersion changes during exercise testing in hypertensive men

8 diallyl disulfide ameliorates isoproterenol induced cardiac hypertrophy activating mitochondrial biogenesis via enos-nrf2-tfam pathway in rats

9 confiabilidade da medida de espessuras musculares pela ultrassonografia reliability of muscle thickness measurements using ultrasound

10 moderate-load muscular endurance strength training did not improve peak power or functional capacity in older men and women

11 proteção miocárdica ao coração hipertrofiado: o eterno desafio myocardial protection to the hypertrophied heart: the eternal challenge

12 right ventricular adaptation in congenital heart diseases

13 genetic background influences adaptation to cardiac hypertrophy and ca2+ handling gene expression

14 heavy resistance training in hypoxia enhances 1rm squat performance

15 satellite cells in human skeletal muscle plasticity

16 myocardial hypertrophy reduces transmural variation in mitochondrial function

17 efeito da colestase nos aspectos funcionais e morfológicos renais após nefrectomia effect of cholestasis on renal morphological and functional aspects after nephrectomy

18 Linking type 2 diabetes mellitus, cardiac hypertrophy and depression in a diurnal animal model

19 Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study

20 Resistance training reduces the metabolic acidosis and hepatic and renal hypertrophy caused by the consumption of a high protein diet in rats

21 Association of asymptomatic otitis media with effusion in patients with adenoid hypertrophy.

22 Intra-Abdominal Fat Adipocyte Hypertrophy through a Progressive Alteration of Lipolysis and Lipogenesis in Metabolic Syndrome Rats.

23 Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

24 Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis.

25 Comorbid CAD and ventricular hypertrophy compromise the perfusion of myocardial tissue at subcritical stenosis of epicardial coronaries

26 Cold water immersion attenuates anabolic signalling and skeletal muscle fiber hypertrophy, but not strength gain, following whole-body resistance training.

27 Right temporal cortical hypertrophy in resilience to trauma: an MRI study

28 Taxifolin ameliorates DEHP-induced cardiomyocyte hypertrophy via attenuating mitochondrial dysfunction and glycometabolism disorder in chicken.

29 Correlation between Ribosome Biogenesis and the Magnitude of Hypertrophy in Overloaded Skeletal Muscle.

30 Artificial intelligence capable of detecting left ventricular hypertrophy: pushing the limits of the electrocardiogram?

31 Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats.

32 Isosteviol prevents the development of isoprenaline‑induced myocardial hypertrophy.

33 Mechanistic insights to the cardioprotective effect of blueberry nutraceutical extract in isoprenaline-induced cardiac hypertrophy.

34 N-Acetyl Cysteine Inhibits Endothelin-1-Induced ROS Dependent Cardiac Hypertrophy through Superoxide Dismutase Regulation

35 [Unusual abnormality of the myocardial structure in so-called idiopathic cardiac hypertrophy]

36 PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

37 Blockade of Sphingosine 1-Phosphate Receptor 2 Signaling Attenuates High-Fat Diet-Induced Adipocyte Hypertrophy and Systemic Glucose Intolerance in Mice

38 [Unusual abnormality of the myocardial structure in so-called idiopathic cardiac hypertrophy].

39 the role of ca2+/calmodulin-dependent protein kinase ii and calcineurin in tnf-α-induced myocardial hypertrophy

40 isolated hemihypertrophy in child

41 bezafibrate attenuates pressure overload-induced cardiac hypertrophy and fibrosis

42 early life stress and macaque amygdala hypertrophy: preliminary evidence for a role for the serotonin transporter gene.

43 montelukast in adenoid hypertrophy: its effect on size and symptoms

44 cytology of nasal mucosa, olfactometry and rhinomanometry in patients after co2 laser mucotomy in inferior turbinate hypertrophy.

45 strength training with repetitions to failure does not provide additional strength and muscle hypertrophy gains in young women

46 synergistic cardiac pathological hypertrophy induced by high-salt diet in igf-iirα cardiac-specific transgenic rats.

47 postural tachycardia syndrome and vasovagal syncope: a hidden case of obstructive cardiomyopathy without severe septal hypertrophy

48 left ventricular hypertrophy evaluation in obese hypertensive patients: effect of left ventricular mass index criteria

49 severe renal vascular hypertension caused by upper left branch renal artery stenosis complicated with multiple thrombosis and cardiac hypertrophy

50 factors affecting results of fluoroscopy-guided facet joint injection: probable differences in the outcome of treatment between pure facet joint hypertrophy and concomitant diseases

51 nutritional interventions to augment resistance training-induced skeletal muscle hypertrophy

52 the temporal expression patterns of the transcription factors and target genes in cardiomyocyte hypertrophy

53 pioglitazone protected against cardiac hypertrophy via inhibiting akt/gsk3β and mapk signaling pathways

54 commentary: left ventricular hypertrophy in pediatric hypertension: a mini review

55 arctiin protects against cardiac hypertrophy through inhibiting mapks and akt signaling pathways

56 analysis of left ventricular hypertrophy predictors in women with different levels of obesity

57 effects of wenxin keli on cardiac hypertrophy and arrhythmia via regulation of the calcium/calmodulin dependent kinase ii signaling pathway

58 effects of a 12-week modified german volume training program on muscle strength and hypertrophy—a pilot study

59 magnetic resonance imaging as problem-solving tool in renal pseudotumor in chronic kidney disease: a case of nodular compensatory hypertrophy

60 in situ split of the liver when portal venous embolization fails to induce hypertrophy: a report of two cases

61 nox2 deficiency prevents hypertension-induced vascular dysfunction and hypertrophy in cerebral arterioles

62 rapamycin inhibits cardiac hypertrophy by promoting autophagy via the mek/erk/beclin-1 pathway

63 global microrna profiles and signaling pathways in the development of cardiac hypertrophy

64 biomechanical implications of skeletal muscle hypertrophy and atrophy: a musculoskeletal model

65 the frequency of left ventricular hypertrophy in patients with arterial hypertension and obese patients with arterial hypertension

66 efeitos da sinvastatina na hipertrofia lipídica da medula óssea induzida pelo uso de corticóides em ratos effects of simvastatin in steroid-induced bone marrow lipidic hypertrophy in rats

67 prevalence of salivary gland hypertrophy syndrome in laboratory colonies and wild flies of <i>glossina pallidipes</i> in ethiopia

68 garlic oil alleviates mapks- and il-6-mediated diabetes-related cardiac hypertrophy in stz-induced dm rats

69 peroxisome proliferator-activated receptor α reduces endothelin-1-caused cardiomyocyte hypertrophy by inhibiting nuclear factor-κb and adiponectin

70 correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist wy-14,643

71 role of micrornas in skeletal muscle hypertrophy

72 histologically measured cardiomyocyte hypertrophy correlates with body height as strongly as with body mass index

73 Mog1 knockout causes cardiac hypertrophy and heart failure by downregulating tbx5-cryab-hspb2 signalling in zebrafish

74 Left Ventricular Hypertrophy in Mild and Moderate Reduction in Kidney Function Determined Using Cardiac Magnetic Resonance Imaging and Cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA)

75 Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis

76 Muscular and Systemic Correlates of Resistance Training-Induced Muscle Hypertrophy

77 746-3 Impaired Wall Thickening of Adjacent Non-Infarcted Myocardium is Associated with Regional Myocyte Hypertrophy and Dysfunction During Post-Infarct Remodeling

78 Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging—The Multi-Ethnic Study of Atherosclerosis (MESA)

79 Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: The Multi-Ethnic Study of Atherosclerosis (MESA)

80 Inhibition of Uncoupling Protein 2 Attenuates Cardiac Hypertrophy Induced by Transverse Aortic Constriction in Mice

81 The Mas agonist CGEN-856S prevents Ang II induced cardiomyocyte hypertrophy via nitric oxide production.

Keyword Connections

Journals

Research Groups

Bibliographies